Send to a Friend Font Size: Increase Decrease

William Ackman

William Ackman's Portfolio

Ticker	# of Shares	Price	Value
GOOG	9,377,195	$346.08	$3,245,259,646
HLT	9,332,853	$343.83	$3,208,914,847
	15,095,528	$195.32	$2,948,458,529
QSR	23,348,135	$71.64	$1,672,660,392
LOW	7,468,850	$213.54	$1,594,898,229
HHC	16,570,228	$78.76	$1,305,071,158
GOOGL	2,185,000	$346.13	$756,294,050
CMG	953,608	$30.95	$29,514,168
View Additional Portfolio Information »

Bill Ackman runs hedge fund Pershing Square Capital, which he started in 2003 following the dissolution of Gotham Partners.

Ackman is a value investor with an activist bent. Activist investors agitate management for changes. He owns large positions in Target (NYSE: TGT) and Borders (NYSE: BGP). He has also been involved in activist situations at Wendy's (NYSE: WEN) and McDonald's (NYSE: MCD).

Ackman proved his acumen as a short seller in 2007/2008 as short positions he held in MBIA (NYSE: MBI) and Ambac (NYSE: ABK) proved to be big winners due to the credit crunch.

In July 2008, Ackman said he was short the common stock of Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE: FRE). Ackman also laid out a plan to reorganize the GSEs, which would wipe out the common shareholders.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Mar 17, 2016 09:31AM Pre-Open Stock Movers 03/17: (VTAE) (RSTI) (AQXP) Higher; (SXE) (ORPN) (SALT) Lower (more...)
Mar 16, 2016 06:19PM After-Hours Stock Movers 03/16: (VTAE) (RSTI) (FDX) Higher; (GES) (SALT) (JBL) Lower (more...)
Mar 16, 2016 06:02PM Ackman sells part of Mondelez stake, has no plans for other sales
Mar 16, 2016 05:28PM Ackman's Pershing Square Trims Stake in Mondelez Int'l (MDLZ) to 5.6%
Mar 16, 2016 05:10PM Valeant Pharma (VRX) Gains on Ackman Chatter
Mar 16, 2016 04:56PM Mondelez Int'l (MDLZ) Lower on Word Ackman Selling Some Stock
Mar 15, 2016 05:02PM Valeant's stock rout serves up $5.3 billion in hedge fund losses
Mar 15, 2016 03:58PM Ackman Said to Add to Valeant Pharma (VRX) Stake - Chatter
Mar 15, 2016 03:24PM Ackman's Pershing Square Said to Support Valeant Pharma (VRX) CEO Pearson; Wants More Oversight - Bloomberg
Mar 15, 2016 11:28AM Ackman's Pershing Square Said Down $666M+ This Week on Valeant Pharma (VRX) Stake
Mar 15, 2016 08:37AM Herbalife (HLF) Shelled Out ~$700,000 Last Year to Protect CEO Johnson
Mar 15, 2016 06:20AM Drugmaker Valeant faces debt default risk; shares plunge 50 percent
Mar 14, 2016 03:37PM Pershing Square Holdings, Ltd. Announces First Quarter 2016 Investor Call and Annual London Investor Meeting
Mar 11, 2016 06:19PM Valeant under pressure to beef up management as new board meets
Mar 10, 2016 02:30PM Hedge funds score tiny gains in February - HFR data
Mar 9, 2016 08:52AM Valeant gives Pershing Square 1 board seat, adds 2 other directors
Mar 9, 2016 08:11AM Valeant gives Pershing Square a seat on its board
Mar 8, 2016 05:32PM After-Hours Stock Movers 03/08: (BUFF) (CISG) (AVAV) Higher; (STEM) (PLNT) (ZAGG) Lower (more...)
Mar 8, 2016 05:01PM Valeant to appoint three new directors as soon as Wednesday: sources
Mar 8, 2016 04:43PM Valeant Pharma (VRX) Said in Talks to Add New Director; May Come from Ackman's Pershing Square
Mar 7, 2016 05:06PM Hedge funds score tiny gains in February: HFR data
Mar 4, 2016 07:00AM WPP 2015 Preliminary Results
Mar 2, 2016 09:32AM Ackman's Pershing Square Down 19.9% YTD in 2016
Mar 1, 2016 06:38PM Ackman's Pershing Square Holdings fund down 19.9 percent in 2016
Feb 29, 2016 02:55PM Boys & Girls Harbor Ninth Annual Harbor Investment Conference to Feature Ideas and Insights of Industry-Leading Investment Managers
Feb 25, 2016 06:15PM Herbalife says it is in talks with FTC; outcome uncertain
Feb 24, 2016 04:50PM Ackman's fund off 17.3 percent for year, erases banner gains from 2014
Feb 12, 2016 07:48PM Loeb says Third Point raised short bets to avoid losses
Feb 12, 2016 01:20PM Oxford Saïd receives new funding for the 1+1 MBA scholarships from the Pershing Square Foundation
Feb 10, 2016 07:12PM Ackman's Pershing Square Holdings down 18.6 percent so far in 2016: investor
Feb 5, 2016 03:12PM Hedge funds post worst start to year since 2008: HFR
Feb 3, 2016 02:11PM 'No Blatant Lies' Seen from Valeant (VRX) CEO/CFO Exchange and Philidor Scripts Were Not Just Smoke and Mirrors - Evercore ISI
Jan 31, 2016 03:34PM Ackman, Herbalife unscathed by probes: WSJ
Jan 27, 2016 05:07PM Ackman's Pershing Square Holdings down 11.2 percent so far in 2016
Jan 26, 2016 07:23PM Ackman acknowledges mistakes in 2015, details changes in portfolio
Jan 26, 2016 10:38AM Portfolios With Purpose Chooses Lumentus as Social Media Agency Of Record
Jan 25, 2016 11:19AM Bernstein Sees Multiple Ways to Win in Mondelez (MDLZ); End-Game Points to M&A
Jan 20, 2016 04:11PM U.S. hedge funds boast lower losses as markets tumble further
Jan 19, 2016 07:06AM Caution, teamwork trumped bravado for some hedge funds in 2015
Jan 6, 2016 09:27AM Pershing Square's Ackman Thinks Interim Valeant (VRX) CEO Schiller Will Do 'Outstanding Job'
Jan 6, 2016 08:43AM Valeant names interim CEO; timing of Pearson's return unknown
Jan 5, 2016 10:53AM Valeant Pharma (VRX) Sees Sharp Upside
Jan 5, 2016 08:51AM Ackman's Pershing Square ends 2015 with 20.5 pct drop
Jan 4, 2016 01:31PM Jana Partners hedge fund down 5.4 percent in 2015: investor update
Dec 31, 2015 05:09PM Ackman's fund sells 5 million Valeant shares to generate tax loss
Dec 31, 2015 04:26PM Ackman's Pershing Square Sold Nearly 5M Shares of Valeant Pharma (VRX) for Tax Purposes
Dec 23, 2015 05:28PM Market Wrap: Durable Goods Orders Outpaced in Nov.; Crude Rises on Surpise Inventory Drop; KaloBios Gets Delisting Notice
Dec 23, 2015 04:45PM Ackman's Pershing Square Having an Up Month in December
Dec 16, 2015 08:40AM Valeant says can contain hit to dermatology, projects 2016 growth
Dec 15, 2015 09:17PM Ackman tells investors that this year could be his firm's worst ever

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed